| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 04/19/2000 | EP0892919A4 Method and apparatus for treatment of human or animal cell samples |
| 04/19/2000 | EP0873126A4 Labeled vitamin d compounds and the use thereof |
| 04/19/2000 | EP0823056A4 Method of carboxy terminal protein or peptide sequencing |
| 04/19/2000 | EP0785941B1 Porphyrin labeling of polynucleotides |
| 04/19/2000 | EP0749580B1 Method and device for detection of specific target cells in specialized or mixed cell populations and solutions containing mixed cell populations |
| 04/19/2000 | EP0717847B1 Use of antibodies against beta-2 microglobulin-free, class i hla molecules to provide hiv diagnostic tests as well as compositions having a protective action against hiv infections |
| 04/19/2000 | EP0550561B1 Purification of cytokeratin fragments |
| 04/19/2000 | CN2374859Y Micro-climate testing device for inside of clothe |
| 04/19/2000 | CN1251170A Recording assay device |
| 04/19/2000 | CN1251169A Method and device for determining stability of water-hydrocarbon emulsion |
| 04/19/2000 | CN1251130A Isolated viable parasate intestinal cells |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/18/2000 | US6052464 Telephone set having a microphone for receiving or an earpiece for generating an acoustic signal via a keypad |
| 04/18/2000 | US6052182 Fiber quality monitor |
| 04/18/2000 | US6051697 Chemokine expressed in eosinophils |
| 04/18/2000 | US6051693 Human monoclonal antibody which preferentially binds to neoplastic cell over a normal cell of same tissue type; for diagnosis, anticarcinogenic agents and antitumor agents |
| 04/18/2000 | US6051691 Amino acid sequence of protein; for screening bactericides and bacteristats especially targeted to streptococci |
| 04/18/2000 | US6051688 Amino acid sequence for polypeptide of at least 6 contiguous amino acids; for diagnosis and treatment of nervous system disorders; anticonvulsants; antiischemic/antihypoxic agents; antiepileptic agents; alzheimer's/parkinson's diseases |
| 04/18/2000 | US6051559 Cloning and characterizing of genes associated with long-term memory |
| 04/18/2000 | US6051436 Using ultraviolet light to photolytically dissociate compositions from surface of solid material into gaseous nitrogen oxides which are detected by gas sensor; accurate, simple detection of wastes, fertilizers and explosives |
| 04/18/2000 | US6051435 Freezing, lyophilizing cold aqueous extraction of plant material, reextracting with dilute boiling hydrochloric acid, analyzing to reveal pattern of carbohydrate multimers to indicate stress; relevant to water stress in cotton plants |
| 04/18/2000 | US6051434 Activated protein C resistance test |
| 04/18/2000 | US6051433 Preparing control by making a suspension of aggregating agent in a synthetic plasma base, then adding mammalian red blood cells; for monitoring accuracy of analysis |
| 04/18/2000 | US6051422 Hybrid biosensors |
| 04/18/2000 | US6051418 Hybrid proteins with modified activity |
| 04/18/2000 | US6051416 Methods for producing enhanced antigenic Helicobacter sp. |
| 04/18/2000 | US6051410 Self-assembled, defective, nonself-propagating viral particles |
| 04/18/2000 | US6051404 A nucleic acid encoding a protein; vaccines for poultry |
| 04/18/2000 | US6051400 An expression system comprising of a polynucleotide encoding a protein; therapy and diagnosis of kidney diseases, cardiovascular disorders, strokes, alzheimer's disease; anticarcinogenic agents and antiinflammatory agents |
| 04/18/2000 | US6051396 Method for producing retinoblastoma gene protein products |
| 04/18/2000 | US6051395 Method and compound for detecting low levels of microorganisms |
| 04/18/2000 | US6051393 Method of detecting malignant and pre-malignant conditions of the cervix, and test kits therefor |
| 04/18/2000 | US6051392 Method for quantitating a substrate and measurement device used therefor |
| 04/18/2000 | US6051390 Indirectly quantitating an enzyme by administering an amount of an inhibitor high molecular weight complex or an inhibitor high molecular weight conjugate that binds to enzyme; measure change in ciruclating concentration of conjugate in blood |
| 04/18/2000 | US6051388 A detecting system using pretreated polyethylene film; enhancing film's ability to immobilize antibodies on surface; agents are protected by abrasion resistant gel coat in which the porosity is to control antibodies migration; food testing |
| 04/18/2000 | US6051387 Methods of determining the presence of a neoplasm with CLNH5- and CLNH11-specific antibodies |
| 04/18/2000 | US6051386 Introducing a stimulant to test cells of a pigment cell line expressing exogenous cell surface receptor to set an initial state of pigment disposition, contacting with test chemical; change in pigment disposition indicates an agonist |
| 04/18/2000 | US6051384 Method of detecting p53-specific antibodies |
| 04/18/2000 | US6051382 Process for recognizing the risk of becoming ill after an arthropod bite |
| 04/18/2000 | US6051381 Escherichia host cell containing a fusion protein, a dna binding domain, protein interacting domain, and a reporter gene linked to a promoter; used as a yeast two-hybrid system; interaction cloning, mapping/analyzing protein interactions |
| 04/18/2000 | US6051379 Oligonucleotides capable of detecting mutations in a tumor suppressor gene at specific locations using an allele specific detection assay; for detection possible development of breast and ovarian cancer |
| 04/18/2000 | US6051377 Multiplex assay for nucleic acids employing transponders |
| 04/18/2000 | US6051376 Uses of mda-6 |
| 04/18/2000 | US6051375 Glycoprotein B of the RFHV/KSHV subfamily of herpes viruses |
| 04/18/2000 | US6051374 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use |
| 04/18/2000 | US6051373 Methods for screening for inhibitors of the transcription-enhancing activity of the X protein of hepatitis B virus |
| 04/18/2000 | US6051229 Human-human hybridom for neoplasms CLNH5 and CLNH11 specific antibody compositions |
| 04/18/2000 | US6051226 use of antibodies targeting the MN oncoprotein conjugated to an anticancer therapeutic agent such as drug or toxin for tissue targeted cancer therapy |
| 04/18/2000 | US6051222 Cancer diagnosis; genetic engineering |
| 04/18/2000 | US6051221 BRK protein tyrosine kinase and encoding nucleic acid |
| 04/18/2000 | US6051126 Determining metal content by measuring the extent to which a biasing voltage is lowered by galvanic action between the sample and a probe conductor embedded in a fibrous absorbent medium containing an electrolyte |
| 04/18/2000 | US6051123 Multi-functional and NOx sensor for combustion systems |
| 04/18/2000 | US6050956 Hemolyzing tube and a method of preparing a hemolysis blood sample within tube |
| 04/18/2000 | US6050149 Device for measuring bending strength of sheet material |
| 04/18/2000 | US6050148 Dynamic strength tester for paper cores |
| 04/18/2000 | US6050139 Devices and methods for testing tack uniformity of a coating on a substrate |
| 04/18/2000 | CA2198607C Cell separation apparatus and method |
| 04/18/2000 | CA2138048C Determination and control of effective alkali in kraft liquors by ir spectroscopy |
| 04/18/2000 | CA2032561C Method of determining levels of extrinsic and intrinsic clotting factors and protein c |
| 04/18/2000 | CA1340966C Method of protein analysis |
| 04/16/2000 | CA2286373A1 Method and apparatus for determining o2 and n2o in gas mixtures |
| 04/16/2000 | CA2284857A1 G protein coupled receptor a4 |
| 04/15/2000 | CA2284853A1 Methods for identifying compounds for inhibition of neoplastic lesions, and pharmaceutical compositions containing such compounds |
| 04/13/2000 | WO2000020872A1 Method to determine a predisposition to leptin treatment |
| 04/13/2000 | WO2000020871A1 Immunodiagnosis of polyneuropathies using heparan sulfate glycosaminoglycan |
| 04/13/2000 | WO2000020870A1 Characterising polypeptides through cleavage and mass spectrometry |
| 04/13/2000 | WO2000020869A1 Detection of pleiotrophin |
| 04/13/2000 | WO2000020868A1 Screen for risk for gastric adenocarcinoma |
| 04/13/2000 | WO2000020867A1 A novel ret-independent signaling pathway for gdnf |
| 04/13/2000 | WO2000020866A1 Assay using porosity-reduction to inhibit migration |
| 04/13/2000 | WO2000020863A1 Toxin detector |
| 04/13/2000 | WO2000020862A1 Process and apparatus for the in vitro detection of multiple analytes |
| 04/13/2000 | WO2000020861A1 Biochip and biochip reading device comprising a plurality of zones for molecular recognition |
| 04/13/2000 | WO2000020860A1 Diagnostic assay for matrix metalloproteinase 9 and use thereof |
| 04/13/2000 | WO2000020859A1 METHOD AND APPARATUS FOR DETECTING BINDING INTERACTIONS $i(IN VIVO) |
| 04/13/2000 | WO2000020858A1 Method and apparatus for inspecting glass containers for checks |
| 04/13/2000 | WO2000020852A1 Conductive organic sensors, arrays and methods of use |
| 04/13/2000 | WO2000020840A1 Tests for the rapid evaluation of ischemic states and kits |
| 04/13/2000 | WO2000020838A1 An apparatus for determining the position of an object |
| 04/13/2000 | WO2000020836A1 Device and method for measuring an index of resistance to damage of metal package coatings |
| 04/13/2000 | WO2000020835A2 Thromboplastin reagents and methods for preparing and using such reagents |
| 04/13/2000 | WO2000020643A1 Reverse displacement assay for detection of nucleic acid sequences |
| 04/13/2000 | WO2000020642A1 Prevention of adhesions |
| 04/13/2000 | WO2000020641A1 Tissue analysis and kits therefor |
| 04/13/2000 | WO2000020640A1 A novel method of diagnosing, monitoring, staging, imaging and treating gastrointestinal cancers |
| 04/13/2000 | WO2000020638A2 Methods and compositions for the diagnosis and therapy of prostate cancer |
| 04/13/2000 | WO2000020636A1 Methods of identifying inverse agonists of the serotonin 2a receptor |
| 04/13/2000 | WO2000020634A1 Methods for treating or identifying a subject at risk for a neurological disease by determining the presence of a variant gpiiia and/or variant gpiib allele |
| 04/13/2000 | WO2000020633A1 Detection of nucleic acid polymorphism |
| 04/13/2000 | WO2000020627A1 Use of ynes, essential bacterial genes and polypeptides |
| 04/13/2000 | WO2000020626A1 Small volume in vitro analyte sensor with diffusible or non-leachable redox mediator |
| 04/13/2000 | WO2000020625A1 In vitro and in vivo models for screening compounds to prevent glucocorticoid-induced bone destruction |
| 04/13/2000 | WO2000020624A1 Use of socs-2 or cis to screen for compounds enhancing growth hormone effect |
| 04/13/2000 | WO2000020621A1 Extracellular novel rage binding protein (en-rage) and uses thereof |
| 04/13/2000 | WO2000020598A1 Peptides useful for reducing symptoms of toxic shock syndrome and septic shock |
| 04/13/2000 | WO2000020591A2 Tgf-beta superfamily mutant members, including morphogenic proteins |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020586A2 Renal cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020564A1 T cells mediating an immune response and methods of use |